PHARCON Inc.
PHARCON Inc.
  • Home
  • SNEDDS
  • TOPICAL NANOEMULSIONS
  • SEIZURES TREATMENT
  • SUBLINGUAL INSULIN
  • NATURAL PRODUCTS
  • Contact Us
  • MICRO- AND NANOPARTICLES
  • ORAL PEPTIDE DELIVERY
  • Advisory board
  • PHARCON Inc. AT A GLANCE
  • PHARCON AT A GLANCE

HIGHLY EFFICIENT ANTI-INFLAMMATORY CREAM

TOPICAL NANOEMULSIONS AS EFFECTIVE DRUG CARIERS

 Rai V., et al.
"Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery"
Journal of Controlled Release Volume 270, 28 January 2018, Pages 203-225

Find out more

TARGETED FOLLICULAR DELIVERY

MINOXIDIL-FINASTERIDE TOPICAL NANOEMULSION

•Water based formulation (oil-in-water nanoemulsion) 

•No propylene glycol, about 6% of alcohol 

•Prepared by dilution of self-nanoemulsifying composition

•Droplet size – about 20 nm 

•Drug loading: Minoxidil – 2 and 4%, Finasteride – 0.5, 0.25% or 0.1% •Minoxidil association with oil droplets: 40-60%

•Finasteride association with oil droplets: 97-100% 

•Room temperature (RT) – stable •Refrigerated (+4oC) – stable

•Particle size and size distribution – stable 

Visible effect (hair growth improvement) – in 8-10 weeks instead of 4-8 months

Copyright © 2026 PHARCON Inc. - All Rights Reserved.

  • Home
  • SNEDDS
  • TOPICAL NANOEMULSIONS
  • SEIZURES TREATMENT
  • SUBLINGUAL INSULIN
  • NATURAL PRODUCTS
  • MICRO- AND NANOPARTICLES
  • ORAL PEPTIDE DELIVERY
  • Advisory board
  • PHARCON AT A GLANCE

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept